NFKB1 and neoplasm: TLRs can promote tumour progression through activating NF-κB signalling, inducing immunosuppressive cytokines and IDO production.94,95 DAMPs and PAMPs in the TME can activate the TLR signalling pathway and lead to tumour metastasis and chemoresistance.